Press release
Deadline on June 4th coming up in Lawsuit for Investors in shares of Checkpoint Therapeutics, Inc. (NASDAQ: CKPT)
A Deadline is coming up on June 4, 2024 in the lawsuit for certain investors in Checkpoint Therapeutics, Inc. (NASDAQ: CKPT).
Investors who purchased shares of Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) have certain options and there are strict and short deadlines running. Deadline: June 4, 2024. NASDAQ: CKPT stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the complaint filed in the U.S. District Court for the Southern District of New York the plaintiff alleges on behalf of purchasers of Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) common shares between March 10, 2021 and December 15, 2023, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between March 10, 2021 and December 15, 2023, the defendants made false and/or misleading statements and/or failed to disclose that Checkpoint had overstated its oversight of, and/or its establishment of adequate manufacturing standards and controls over, its third-party contract manufacturers, that accordingly, there were one or more issues with the Company's third-party contract manufacturing organization ("CMO") for cosibelimab, that all the foregoing reduced the likelihood that the FDA would approve the cosibelimab BLA in its present form, that as a result, the manufacturing, regulatory, and commercial prospects of cosibelimab were overstated, and that as a result, the Company's public statements were materially false and misleading at all relevant times.
Those who purchased shares of Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Deadline on June 4th coming up in Lawsuit for Investors in shares of Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) here
News-ID: 3509104 • Views: …
More Releases from Shareholders Foundation, Inc.
Ready Capital Corporation (NYSE: RC) Long Term Investor Investigation of potenti …
An investigation was announced for potential breaches of fiduciary duties by certain directors and officers of Ready Capital Corporation.
Investors who are current long term investors in Ready Capital Corporation (NYSE: RC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NYSE: RC stocks follows a lawsuit filed against Ready…
Investigation announced for Long-Term Investors in shares of Digimarc Corporatio …
An investigation was announced for current long-term investors in shares of Digimarc Corporation (NASDAQ: DMRC) concerning potential breaches of fiduciary duties by certain directors of Digimarc Corporation.
Investors who are current long term investors in Digimarc Corporation (NASDAQ: DMRC) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: DMRC…
Ultra Clean Holdings, Inc. (NASDAQ: UCTT) Investor Alert: Deadline in Lawsuit on …
A deadline is coming up on May 23, 2025 in the lawsuit filed for certain investors of Ultra Clean Holdings, Inc. (NASDAQ: UCTT) over alleged securities laws violations by Ultra Clean Holdings, Inc.
Investors who purchased shares of Ultra Clean Holdings, Inc. (NASDAQ: UCTT) have certain options and there are strict and short deadlines running. Deadline: May 23, 2025. Ultra Clean Holdings, Inc. (NASDAQ: UCTT) stockholders should contact the Shareholders…
Lawsuit filed for Investors who lost money with shares of West Pharmaceutical Se …
An investor, who purchased shares of West Pharmaceutical Services, Inc. (NYSE: WST), filed a lawsuit in the U.S. District Court for the Eastern District of Pennsylvania over alleged violations of Federal Securities Laws by West Pharmaceutical Services, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of West Pharmaceutical Services, Inc. (NYSE: WST) have certain options and for certain investors are short and strict deadlines running.…
More Releases for Checkpoint
Immune Checkpoint Inhibitors Market: Current Evidence And Future Perspectives Of …
Stratagem Market Insights delivers key insights for the Immune Checkpoint Inhibitors market in its published report, which include global industry analysis, Size, Growth, Opportunities, Emerging Trends, Challenges, and Geographic Regions over the forecast period (2021-2028). In terms of revenue, the global Immune Checkpoint Inhibitors market is projected to grow at a CAGR of XX% during the forecast period, owing to several factors about which SMI offers detailed insights and forecasts…
Immune Checkpoint Inhibitor
Immune Checkpoint Inhibitors Market Insights 2019, Global and Chinese Scenario is a professional and indepth study on the current state of the global Immune Checkpoint Inhibitors industry with a focus on the Chinese market. The report provides key statistics on the market status of the Immune Checkpoint Inhibitors manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Overall, the report provides an…
Global Checkpoint Inhibitors Market 2019 Snapshot Analysis Till 2023
Global Checkpoint Inhibitors Market 2019-2023:
The treatment of cancer patients involves a multidisciplinary approach encompassing surgery, radiotherapy, and chemotherapy. Traditionally, patients with metastatic disease are treated with combination cytotoxic chemotherapy or targeted agents; although chemotherapy treatment has good response rates complete responses are rarely seen. During the last decade the field of immuno-oncology has rapidly advanced and a number of agents which modulate the immune system are beginning to emerge and…
PDF Checkpoint 1.8.5 Improves Color Conversion Handling
Zevrix Solutions announces PDF Checkpoint 1.8.5, a maintenance update to company's PDF preflight and conversion solution. Remarkably fast, PDF Checkpoint automatically preflights, exports as images, splits and optimizes Adobe PDF files. The helps users eliminate costly mistakes and optimize PDF documents for print, web and mobile devices. The new version improves handling of installed ICC profiles which are used to perform conversion of PDF files to different color spaces.
Toronto (ON),…
Global Checkpoint Inhibitors Market Shares and its growth
Global Checkpoint Inhibitors Market was worth USD 6.08 billion in 2016 and is expected to reach USD 21.25 billion by 2021 with a CAGR of 28.4 %.
Checkpoint Inhibitors are drugs used in Immunotherapy. They are generally made up of antibodies that lead an immune system attack on cancer cells. T-cells launches an attack when it detects infected or Cancerous. Immune system uses a series of molecules called checkpoint molecules to…
PDF Checkpoint Now Can Preflight PDF Document Font Names
Toronto (ON), Canada -- Zevrix Solutions today announces PDF Checkpoint 1.7.19, a feature update to the company's PDF preflight and conversion automation tool (http://www.zevrix.com/PDFCheckpoint.php). Remarkably fast, PDF Checkpoint automatically preflights, exports as images, splits and optimizes multiple PDF documents. PDF Checkpoint is an ideal program for users who need a fast, affordable and easy to use solution to check PDF files for errors and prepare them for print, web and…
